🇺🇸 FDA
Patent

US 8318765

3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

granted A61KA61K31/197A61K31/485

Quick answer

US patent 8318765 (3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists) held by Theravance, Inc. expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/197, A61K31/485, A61K45/06, A61K47/02